| Literature DB >> 15177303 |
Andrew B Seidenberg1, Yuehuei H An.
Abstract
The use of the new selective cyclooxygenase-2 (COX-2) inhibitors (such as celecoxib and rofecoxib) for the treatment of pain and inflammation caused by fractures, cementless total joint replacements, soft tissue healing to bone, and spinal fusion surgeries has been controversial due to the convincing data collected from nonspecific NSAIDs such as indomethacin and naproxen regarding their inhibitory effects on bone healing and the similar effects of COX-2 specific NSAIDs in animal models. Is there a significant inhibitory effect of COX-2 inhibitors on bone healing in humans? To answer this question, we reviewed existing scientific evidence (based mainly on a MedLine search) of the potential effects of COX-2 inhibitors on bone healing. The literature shows that COX-2 inhibitors do have inhibitory effects on bone healing in animal models, but the effects of COX-2 inhibitors on similar processes in humans remain largely unknown. Copyright 2004 Elsevier Ltd.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15177303 DOI： 10.1016/j.phrs.2003.12.017
Source DB: PubMed Journal: Pharmacol Res ISSN： 1043-6618 Impact factor: 7.658